Neuraptive Therapeutics, Inc. is a biotechnology company dedicated to developing novel therapeutics and medical products to address the unmet needs of physicians and patients impacted by peripheral nerve injuries.
--(BUSINESS WIRE)-- Neuraptive Therapeutics, Inc. is a biotechnology company dedicated to developing novel therapeutics and medical products to address the unmet needs of physicians and patients impacted by peripheral nerve injuries.
|
Company: |
Neuraptive Therapeutics, Inc. |
||
|
|
|
||
|
Headquarters Address: |
2 Logan Square |
||
|
|
Suite 1930 |
||
|
|
Philadelphia, PA 19103 |
||
|
|
|
||
|
Main Telephone: |
617-794-6442 |
||
|
|
|
||
|
Website: |
|||
|
|
|
||
|
Type of Organization: |
Private |
||
|
|
|
||
|
Industry: |
Biotechnology |
||
|
|
|
||
|
Key Executives: |
EVP, Head of R&D: Evan Tzanis |
||
|
|
|
||
|
EVP, Head of R&D |
|
||
|
Contact: |
Evan Tzanis |
||
|
Phone: |
617-794-6442 |
||
|
Email: |
View source version on businesswire.com: https://www.businesswire.com/news/home/20200428006022/en/
Source: Neuraptive Therapeutics, Inc.
View this news release online at:
http://www.businesswire.com/news/home/20200428006022/en
